Home > Publications database > Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial. > print

001     294645
005     20241126113051.0
024 7 _ |a 10.1002/hem3.70052
|2 doi
024 7 _ |a pmid:39569355
|2 pmid
024 7 _ |a pmc:PMC11577299
|2 pmc
024 7 _ |a altmetric:170936465
|2 altmetric
037 _ _ |a DKFZ-2024-02389
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Mai, Elias K
|0 0000-0002-6226-1252
|b 0
245 _ _ |a Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial.
260 _ _ |a [Philadelphia, Pennsylvania]
|c 2024
|b Wolters Kluwer Health
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1732617031_1379
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Nogai, Axel
|b 1
700 1 _ |a Lokhorst, Henk M
|b 2
700 1 _ |a van der Holt, Bronno
|0 0000-0001-6414-2671
|b 3
700 1 _ |a Zweegman, Sonja
|b 4
700 1 _ |a Weisel, Katja C
|b 5
700 1 _ |a Croockewit, Sandra
|b 6
700 1 _ |a Jauch, Anna
|b 7
700 1 _ |a Hillengass, Jens
|b 8
700 1 _ |a Stevens-Kroef, Marian
|b 9
700 1 _ |a Raab, Marc S
|b 10
700 1 _ |a Broijl, Annemiek
|b 11
700 1 _ |a Bos, Gerard M J
|b 12
700 1 _ |a Brossart, Peter
|b 13
700 1 _ |a Ypma, Paula
|b 14
700 1 _ |a Hanoun, Christine
|0 0000-0003-2766-1696
|b 15
700 1 _ |a Bertsch, Uta
|b 16
700 1 _ |a Hielscher, Thomas
|0 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
|b 17
|u dkfz
700 1 _ |a Salwender, Hans J
|b 18
700 1 _ |a Scheid, Christoph
|b 19
700 1 _ |a Goldschmidt, Hartmut
|b 20
700 1 _ |a Sonneveld, Pieter
|b 21
773 _ _ |a 10.1002/hem3.70052
|g Vol. 8, no. 11, p. e70052
|0 PERI:(DE-600)2922183-3
|n 11
|p e70052
|t HemaSphere
|v 8
|y 2024
|x 2572-9241
909 C O |p VDB
|o oai:inrepo02.dkfz.de:294645
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HEMASPHERE : 2022
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-06-14T08:57:17Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-06-14T08:57:17Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Double anonymous peer review
|d 2023-06-14T08:57:17Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b HEMASPHERE : 2022
|d 2023-10-27
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-10-27
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-10-27
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21